![Her2/Neu Antibody[P1002]产品图](https://img1.dxycdn.com/p/s14/2025/0923/278/4431488150116040791.jpg)
- 询价
- Signalway Antibody
- P1002
- 2025年09月23日
- IHC
- Mouse
- Human
企业认证
相关产品推荐更多 >
![MAP4K3 Antibody[35951]](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg!wh200)
![GPR49/LGR5 Polyclonal Antibody APC Conjugated[C91519APC]](https://img1.dxycdn.com/p/s14/2025/0922/498/0460884283108299691.jpg!wh200)
![RBP1 Conjugated Antibody[C27262]](https://img1.dxycdn.com/p/s14/2025/0923/305/2150219664296040791.jpg!wh200)
![CACNB4 Antibody[46386]](https://img1.dxycdn.com/p/s14/2025/0923/496/0462304380155040791.jpg!wh200)
![VPS24 Conjugated Antibody[C56672]](https://img1.dxycdn.com/p/s14/2025/0922/632/2321321568067599691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起，权威机构信任 15+ 年Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Monoclonal
- 适应物种：
Human
- 保质期：
12 months
- 抗原来源：
Mouse
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Mouse
- 应用范围：
IHC
- 抗体英文名：
Her2/Neu Antibody
- 规格：
50ul/100ul
应用详情:Recommended working dilution range:1:100 - 1:200
图片:
Her2/Neu Antibody (P1002) on Breast carcinoma
,
Her2/Neu Antibody (P1002) on Breast - 10X
,
Her2/Neu Antibody (P1002) on Breast - 40X
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验HER2/neu DNA Vaccination for Breast Tumors
Several studies of DNA vaccination against HER2/neu showed the effectiveness of immunization protocols in models of transplantable or spontaneous tumors. The DNA delivery system plays a crucial role in the success of DNA vaccination
Automated Analysis of FISH-Stained HER2/neu Samples with Metafer
The HER2/neu gene (also known as ERBB2) is located on chromosome 17 (q11.2–q12) and encodes a glycoprotein known to be a member of the epidermal growth factor receptor family. Clinically, the determination of its amplification status
Developing Anti-HER2/neu Single-Chain Fv Fragments from Phage Display Libraries
One of the major failures of conventional cancer therapy has been the inability to achieve a sufficient differential in toxicity between normal and neoplastic tissues. Since hybridoma technology was established (1 ), monoclonal antibodies
技术资料暂无技术资料 索取技术资料
